Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-28 Wan Jerry Principal Accounting Officer Grant or award · Stock Option (right to buy) +70,300 70,300
2025-09-04 Wan Jerry Principal Accounting Officer Exercise or conversion +34,100 46,764
2025-09-04 Wan Jerry Principal Accounting Officer Sale −14,070 $2.77 $39K 32,694
2025-09-04 Wan Jerry Principal Accounting Officer Exercise or conversion · Performance Restricted Stock Unit (PRSU) −24,500 0
2025-09-04 Wan Jerry Principal Accounting Officer Exercise or conversion · Performance Restricted Stock Unit (PRSU) −9,600 38,400
2025-01-28 Wan Jerry Principal Accounting Officer Grant or award · Performance Restricted Stock Unit (PRSU) +48,000 48,000
2024-08-16 Wan Jerry Principal Accounting Officer Grant or award +2,857 $3.67 $10K 12,664
2024-04-19 Wan Jerry Principal Accounting Officer Exercise or conversion +5,625 12,057
2024-04-19 Wan Jerry Principal Accounting Officer Shares withheld for taxes −2,250 $4.51 $10K 9,807
2024-04-19 Wan Jerry Principal Accounting Officer Exercise or conversion · Performance Restricted Stock Unit (PRSU) −5,625 0
2024-01-22 Wan Jerry Principal Accounting Officer Grant or award · Performance Restricted Stock Unit (PRSU) +24,500 24,500
2024-01-22 Wan Jerry Principal Accounting Officer Grant or award · Stock Option (right to buy) +10,500 10,500
2023-04-28 Wan Jerry Principal Accounting Officer Exercise or conversion +1,250 7,101
2023-04-28 Wan Jerry Principal Accounting Officer Shares withheld for taxes −669 $8.29 $6K 6,432
2023-04-28 Wan Jerry Principal Accounting Officer Exercise or conversion · Performance Restricted Stock Unit (PRSU) −1,250 0
2023-04-21 Wan Jerry Principal Accounting Officer Exercise or conversion +5,625 8,861
2023-04-21 Wan Jerry Principal Accounting Officer Shares withheld for taxes −3,010 $6.80 $20K 5,851
2023-04-21 Wan Jerry Principal Accounting Officer Exercise or conversion · Performance Restricted Stock Unit (PRSU) +5,625 5,625
2023-01-25 Wan Jerry Principal Accounting Officer Grant or award · Performance Restricted Stock Unit (PRSU) +15,000 15,000
2023-01-25 Wan Jerry Principal Accounting Officer Grant or award · Stock Option (right to buy) +15,000 15,000

Page 1 of 2 · 30 trades